Chong Kun Dang Pharmaceutical (XKRX:185750) Ending Cash Position : ₩213,626 Mil (As of Mar. 2024)

View and export this data going back to 2013. Start your Free Trial

What is Chong Kun Dang Pharmaceutical Ending Cash Position?

Chong Kun Dang Pharmaceutical's Ending Cash Position for the quarter that ended in Mar. 2024 was ₩213,626 Mil.

Chong Kun Dang Pharmaceutical's quarterly Ending Cash Position declined from Sep. 2023 (₩226,050 Mil) to Dec. 2023 (₩219,646 Mil) and declined from Dec. 2023 (₩219,646 Mil) to Mar. 2024 (₩213,626 Mil).

Chong Kun Dang Pharmaceutical's annual Ending Cash Position declined from Dec. 2021 (₩131,813 Mil) to Dec. 2022 (₩117,417 Mil) but then increased from Dec. 2022 (₩117,417 Mil) to Dec. 2023 (₩219,646 Mil).

Chong Kun Dang Pharmaceutical Ending Cash Position Historical Data

The historical data trend for Chong Kun Dang Pharmaceutical's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chong Kun Dang Pharmaceutical Ending Cash Position Chart

Chong Kun Dang Pharmaceutical Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

Get a 7-Day Free Trial

76,922.52

123,659.08

131,812.68

117,416.90

219,646.35

Chong Kun Dang Pharmaceutical Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Ending Cash Position	Get a 7-Day Free Trial															150,881.78	146,154.53	226,049.67	219,646.35	213,625.57

Chong Kun Dang Pharmaceutical Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Chong Kun Dang Pharmaceutical's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	117416.899	+	102229.449
	=	219,646

Chong Kun Dang Pharmaceutical's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	219646.349	+	-6020.783
	=	213,626

Chong Kun Dang Pharmaceutical Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Chong Kun Dang Pharmaceutical's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Chong Kun Dang Pharmaceutical (XKRX:185750) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Chong Kun Dang Pharmaceutical Corp (XKRX:185750) » Definitions » Ending Cash Position

Traded in Other Exchanges

N/A

Address

368 Chungjungro-3Ga, Seodaemun-gu, Seoul, KOR, 120-756

Website

http://chongkundang.en.ec21.com

Chong Kun Dang Pharmaceutical Corp. is a manufacturer of antibiotics. The company manufactures and distributes over 130 ethical, OTC pharmaceuticals and pharmaceutical active ingredients, primarily focusing on the application of its advanced technologies in fermentation and organic synthesis. The product range includes Rifampicin (antituberculosis), DMCT (raw material for Minocycline), Cephalosporins, 7-ACA and other intermediates of Cephalosporins, Cyclosporin A (immunosuppressant) and Lovastatin (antihyperlipidaemic agent).

Chong Kun Dang Pharmaceutical (XKRX:185750) Headlines

No Headlines